Optic disc and visual field changes after trabeculectomy

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 10, 2009, Pages 4693-4699

  Kotecha, Aachal ^a,b,c   Spratt, Alexander ^b   Bunce, Catey ^b   Garway Heath, David F ^a,b,c   Khaw, Peng T ^a,b   Viswanathan, Ananth ^b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c CITY UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; PLACEBO; ANTIMETABOLITE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GLAUCOMA; HUMAN; HUMAN TISSUE; INTRAOCULAR PRESSURE; INTRAOPERATIVE PERIOD; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OPTIC DISK; OPTIC NERVE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TRABECULECTOMY; TREATMENT RESPONSE; VISUAL FIELD; DOUBLE BLIND PROCEDURE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OCULOPLETHYSMOGRAPHY; OPTIC NERVE DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PERIMETRY; PHYSIOLOGY; VISUAL DISORDER;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; FLUOROURACIL; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OPTIC DISK; OPTIC NERVE DISEASES; PERIMETRY; PROSPECTIVE STUDIES; TONOMETRY, OCULAR; TRABECULECTOMY; VISION DISORDERS; VISUAL FIELDS;

EID: 70349568515     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-3115     Document Type: Article

References (41)

1. Sommer A, Katz J, Quigley HA, et al. Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch Ophthalmol. 1991;109(1):77-83.
2. The AGIS Investigators. 7. The relationship between control of intraocular pressure and visual field deterioration. The Advanced Glaucoma Intervention Study (AGIS). Am J Ophthalmol. 2000; 130(4):429-440.
3. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):714-20; discussion 829-830.
4. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268-1279.
5. The AGIS Investigators. 2. Visual field test scoring and reliability. Advanced Glaucoma Intervention Study. Ophthalmology. 1994; 101(8):1445-1355.
6. Musch DC, Lichter PR, Guire KE, et al. The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. 1999;106(4): 653-662.
7. Heijl A, Leske MC, Bengtsson B, et al. Measuring visual field progression in the Early Manifest Glaucoma Trial. Acta Ophthalmol Scand. 2003;81(3):286-293.
8. Fitzke FW, Hitchings RA, Poinoosawmy D, et al. Analysis of visual field progression in glaucoma. Br J Ophthalmol. 1996;80(1):40-48.
9. Viswanathan AC, Hitchings RA, Fitzke FW. How often do patients need visual field tests? Graefes Arch Clin Exp Ophthalmol. 1997; 235(9):563-568.
10. Vesti E, Johnson CA, Chauhan BC. Comparison of different methods for detecting glaucomatous visual field progression. Invest Ophthalmol Vis Sci. 2003;44(9):3873-3879.
11. Nouri-Mahdavi K, Caprioli J, Coleman AL, et al. Pointwise linear regression for evaluation of visual field outcomes and comparison with the advanced glaucoma intervention study methods. Arch Ophthalmol. 2005;123(2):193-199.
12. Strouthidis NG, Garway-Heath DF. New developments in Heidelberg retina tomograph for glaucoma. Curr Opin Ophthalmol. 2008;19(2):141-148.
13. Johnson C, Cioffi GA, Liebmann JR, et al. The relationship between structural and functional alterations in glaucoma: a review. Semin Ophthalmol. 2000;15:221-233.
14. Artes PH, Chauhan BC. Longitudinal changes in the visual field and optic disc in glaucoma. Prog Retin Eye Res. 2005;24(3):333-354.
15. Strouthidis NG, Scott A, Peter NM, et al. Optic disc and visual field progression in ocular hypertensive subjects: detection rates, specificity, and agreement. Invest Ophthalmol Vis Sci. 2006;47(7): 2904-2910.
16. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6): 701-13; discussion 829-830.
17. Kamal DS, Garway-Heath DF, Hitchings RA, et al. Use of sequential Heidelberg retina tomograph images to identify changes at the optic disc in ocular hypertensive patients at risk of developing glaucoma. Br J Ophthalmol. 2000;84(9):993-998.
18. Chauhan BC, McCormick TA, Nicolela MT, et al. Optic disc and visual field changes in a prospective longitudinal study of patients with glaucoma: comparison of scanning laser tomography with conventional perimetry and optic disc photography. Arch Ophthalmol. 2001;119(10):1492-1499.
19. Strouthidis NG, White ET, Owen VM, et al. Improving the repeatability of Heidelberg retina tomograph and Heidelberg retina tomography II rim area measurements. Br J Ophthalmol. 2005; 89(11):1433-1437.
20. Gardiner SK, Crabb DP. Examination of different pointwise linear regression methods for determining visual field progression. Invest Ophthalmol Vis Sci. 2002;43(5):1400-1407.
21. Gardiner SK, Crabb DP. Frequency of testing for detecting visual field progression. Br J Ophthalmol. 2002;86(5):560-564.
22. Chauhan BC, Garway-Heath DF, Goni FJ, et al. Practical recommendations for measuring rates of visual field change in glaucoma. Br J Ophthalmol. 2008;92(4):569-573.
23. Garway-Heath DF, Poinoosawmy D, Fitzke FW, et al. Mapping the visual field to the optic disc in normal tension glaucoma eyes. Ophthalmology. 2000;107(10):1809-1815.
24. Bergea B, Bodin L, Svedbergh B. Impact of intraocular pressure regulation on visual fields in open-angle glaucoma. Ophthalmology. 1999;106(5):997-1004; discussion 1004-1005.
25. Nouri-Mahdavi K, Hoffman D, Coleman AL, et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology. 2004;111(9):1627-1635.
26. Hong S, Seong GJ, Hong YJ. Long-term intraocular pressure fluctuation and progressive visual field deterioration in patients with glaucoma and low intraocular pressures after a triple procedure. Arch Ophthalmol. 2007;125(8):1010-1013.
27. Membrey WL, Bunce C, Poinoosawmy DP, et al. Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 2. Visual field progression. Br J Ophthalmol. 2001; 85(6):696-701.
28. Klein BE, Klein R, Linton KL. Prevalence of age-related lens opacities in a population. The Beaver Dam Eye Study. Ophthalmology. 1992;99(4):546-552.
29. Chen PP, Budenz DL. The effects of cataract extraction on the visual field of eyes with chronic open-angle glaucoma. Am J Ophthalmol. 1998;125(3):325-333.
30. Spry PG, Bates AB, Johnson CA, et al. Simulation of longitudinal threshold visual field data. Invest Ophthalmol Vis Sci. 2000;41(8): 2192-2200.
31. Wilkins MR, Fitzke FW, Khaw PT. Pointwise linear progression criteria and the detection of visual field change in a glaucoma trial. Eye. 2006;20(1):98-106.
32. Gardiner SK, Crabb DP, Fitzke FW, et al. Reducing noise in suspected glaucomatous visual fields by using a new spatial filter. Vision Res. 2004;44(8):839-848.
33. Strouthidis NG, Scott A, Viswanathan AC, et al. Monitoring glaucomatous visual field progression: the effect of a novel spatial filter. Invest Ophthalmol Vis Sci. 2007;48(1):251-257.
34. Nouri Mahdavi K, Brigatti L, Weitzman M, et al. Outcomes of trabeculectomy for primary open-angle glaucoma. Ophthalmology. 1995;102(12):1760-1769.
35. Ehrnrooth P, Puska P, Lehto I, et al. Progression of visual field defects and visual loss in trabeculectomized eyes. Graefes Arch Clin Exp Ophthalmol. 2005;243(8):741-747.
36. Leske MC, Heijl A, Hyman L, et al. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007; 114(11):1965-1972.
37. Drance SM. The significance of the diurnal tension variations in normal and glaucomatous eyes. Arch Ophthalmol. 1960;64:494-501.
38. Asrani S, Zeimer R, Wilensky J, et al. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma. 2000;9(2):134-142.
39. Wilensky JT. The role of diurnal pressure measurements in the management of open angle glaucoma. Curr Opin Ophthalmol. 2004;15(2):90-92.
40. Lee PP, Walt JW, Rosenblatt LC, et al. Association between intraocular pressure variation and glaucoma progression: data from a United States chart review. Am J Ophthalmol. 2007;144(6):901-907.
41. Bengtsson B, Leske MC, Hyman L, et al. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial. Ophthalmology. 2007;114(2):205-209.